Related Experiment Video
Updated: Mar 1, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
Anca Daniela Farcaş1,2, Florin Petru Anton1,2, Cerasela Mihaela Goidescu1,2
1"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Insights
Serum ST2 levels can help detect cardiac remodeling and diastolic dysfunction in hypertension. This biomarker offers valuable insights beyond traditional echocardiography for early detection of heart performance changes.
Area of Science:
- Cardiology
- Biomarker Research
- Hypertension Management
Background:
- Echocardiography has limitations in assessing hypertensive left ventricular (LV) changes.
- Serum ST2, a known prognostic biomarker, is understudied in hypertension.
Purpose of the Study:
- To investigate the association between serum ST2 levels and diastolic dysfunction (DD) in hypertensive patients.
- To explore ST2 as a potential biomarker for cardiac remodeling in hypertension.
Main Methods:
- Prospective study of 88 hypertensive outpatients (mean age 65).
- Stratification based on left ventricular hypertrophy (LVH).
- Clinical examination, routine lab work, serum ST2 measurement, and echocardiography were performed.
Main Results:
- Patients with LVH showed higher age, blood pressure, and serum ST2 levels.
- Serum ST2 levels correlated significantly with LV remodeling and DD parameters.
- Identified cut-off values for discriminating LVH and diastolic dysfunction grades.
Conclusions:
- ST2 shows potential as a diagnostic biomarker for cardiac remodeling and diastolic dysfunction in hypertension.
- ST2 can supplement echocardiography, aiding in the early detection of cardiac performance alterations.
Background:
Echocardiographic evaluation of left ventricular (LV) structural and functional alterations in hypertension has some limitations, potentially overcome by using biomarkers. ST2, a prognostic biomarker for heart failure and myocardial infarction patients, was less studied in hypertension.
Aim:
To analyze the relationship between serum ST2 levels and diastolic dysfunction (DD) in hypertension.
Method:
We enrolled 88 hypertensive outpatients (average age 65 years, 69.3% females) in a prospective study, stratified for presence of LV hypertrophy (LVH). For each patient clinical examination, lab workup (routine and serum ST2 levels) and echocardiography were performed.
Results:
Hypertensive patients with LVH had higher age, pulse pressure, mean arterial pressure, and serum ST2, while having lower serum albumin than those without LVH. Serum ST2 levels correlate with parameters of LV remodeling and DD. We found that 5.3% of ST2 level variability was caused by a 1-unit variation of cardiovascular risk. We identified cut-off values for discriminating hypertension with LVH versus that without LVH and grade 2 DD versus normal diastolic performance.
Conclusion:
ST2 could be used as diagnostic biomarker for cardiac remodeling and altered diastolic performance in hypertension, providing additional data to echocardiography. It could represent a milestone in early detection of cardiac performance alteration.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessment of blood pressure in brachial artery(two-step method)

